<?xml version="1.0" encoding="UTF-8"?>
<ref id="B73-pharmaceutics-13-00387">
 <label>73.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <collab>PRIMEX PHARMACEUTICALS</collab>
  </person-group>
  <article-title>OzalinÂ® 2 mg/mL. Package Leaflet: Information for the User</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://mri.cts-mrp.eu/Human/Downloads/FR_H_0610_001_FinalPL.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">https://mri.cts-mrp.eu/Human/Downloads/FR_H_0610_001_FinalPL.pdf</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-08-04">(accessed on 4 August 2020)</date-in-citation>
 </element-citation>
</ref>
